Target type: molecularfunction
Catalysis of the reaction: a 1,2-diacyl-sn-glycerol + ATP = a 1,2-diacyl-sn-glycero-3-phosphate + ADP + H+. [GOC:elh, RHEA:10272]
ATP-dependent diacylglycerol kinase (DAG kinase) activity is a critical enzyme responsible for the phosphorylation of diacylglycerol (DAG) to phosphatidic acid (PA). This process, termed diacylglycerol phosphorylation, is a central regulatory step in cellular signaling and lipid metabolism.
DAG kinases utilize ATP as a phosphate donor to catalyze the transfer of a phosphate group to the sn-3 hydroxyl group of DAG, generating PA. This reaction is reversible, but under physiological conditions, the forward reaction (DAG to PA) is favored.
The molecular function of DAG kinase involves several crucial steps:
1. **Substrate Binding:** The enzyme binds to DAG and ATP, positioning them correctly for the phosphorylation reaction.
2. **Phosphorylation:** The enzyme's active site contains catalytic residues that facilitate the transfer of a phosphate group from ATP to DAG.
3. **Product Release:** Following phosphorylation, PA and ADP are released from the enzyme, completing the catalytic cycle.
DAG kinase activity is modulated by various factors, including:
- **Lipid Binding:** The enzyme has a high affinity for membrane lipids, particularly DAG. This affinity helps to localize the enzyme to the membrane, where DAG is readily available.
- **Calcium Ions:** Calcium ions can activate DAG kinases, enhancing their activity and promoting PA production.
- **Phosphoinositides:** Phosphoinositides, like phosphatidylinositol 4,5-bisphosphate (PIP2), can interact with DAG kinases, influencing their activity and localization.
The precise molecular mechanisms underlying these regulatory events are still under investigation, but they highlight the dynamic nature of DAG kinase activity within the cell.
Overall, ATP-dependent diacylglycerol kinase activity plays a critical role in cellular signaling by:
- **Controlling DAG Levels:** DAG kinase activity removes DAG from the membrane, affecting downstream signaling pathways that are regulated by DAG, such as protein kinase C (PKC) activation.
- **Generating PA:** PA is a key signaling lipid with diverse functions, including activation of phospholipases, regulation of membrane trafficking, and involvement in cell growth and survival.
- **Modulating Membrane Composition:** The conversion of DAG to PA can impact membrane composition and fluidity, influencing cellular processes like membrane fusion and exocytosis.
Therefore, understanding the molecular function of DAG kinase is essential for deciphering the complex interplay of lipid signaling pathways within the cell.'
"
Protein | Definition | Taxonomy |
---|---|---|
Diacylglycerol kinase alpha | A diacylglycerol kinase alpha that is encoded in the genome of human. [PRO:DNx, UniProtKB:P23743] | Homo sapiens (human) |
Diacylglycerol kinase alpha | A diacylglycerol kinase alpha that is encoded in the genome of human. [PRO:DNx, UniProtKB:P23743] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
r 59022 | R 59022: diacylglycerol kinase inhibitor; structure given in first source; platelet activator factor antagonist | diarylmethane | |
dioctanoyl ethylene glycol | |||
ritanserin | ritanserin : A thiazolopyrimidine that is 5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one which is substituted at position 7 by a methyl group and at position 6 by a 2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl group. A potent and long-acting seratonin (5-hydroxytryptamine, 5-HT) antagonist of the subtype 5-HT2 (Ki = 0.39 nM), it is used in the treatment of a variety of disorders including anxiety, depression and schizophrenia. It has little sedative action. Ritanserin: A selective and potent serotonin-2 antagonist that is effective in the treatment of a variety of syndromes related to anxiety and depression. The drug also improves the subjective quality of sleep and decreases portal pressure. | organofluorine compound; piperidines; thiazolopyrimidine | antidepressant; antipsychotic agent; anxiolytic drug; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; serotonergic antagonist |
cochlioquinone a | cochlioquinone A: from Helminthosporium sativum; competitive inhibitor of ivermectin binding; RN from Chem Abstract Index Guide 1990; structure given in first source | oxanes | |
r 59949 | R 59949: diacylglycerol kinase inhibitor | diarylmethane | |
1-monooleoyl-rac-glycerol | 1-oleoylglycerol : A 1-monoglyceride where the acyl group is oleoyl. monooleoylglycerol : A monoglyceride in which the acyl group is oleoyl with the position of acylation unspecified. Peceol: lipid excipient containing readily dispersible mixture of mono- & diglycerides of oleic acid | 1-acylglycerol 18:1; monooleoylglycerol | plant metabolite |
stemphone | stemphone: structure given in first source |